Zong Li-li, Li Ya-li, Song San-tai, Jiang Ze-fei, Zhao Jun
Department of Oncology, 307 Hospital of Academy of Military Medical Sciences, Beijing 100850, China.
Di Yi Jun Yi Da Xue Xue Bao. 2004 Jun;24(6):619-22.
To study the role of hepatocyte growth factor (HGF) and its receptor (c-Met) in the pathogenesis of endometriosis.
In situ hybridization and immunohistochemistry method was used to examine HGF mRNA and protein expression in eutopic and ectopic endometrium obtained from 54 women in reproductive age with endometriosis confirmed by laparoscopy and histological examination (including 28 cases of stages I/II and 26 of stages III/IV) and from the endometrium of 24 healthy fertile women.
In patients with endometriosis, the positivity rate of HGF/c-Met expression was similar in the eutopic and ectopic endometria, but the number of positive cells and expression intensity were much higher in ectopic endometrium. The positive expression rate varied little between the proliferative and secretory stages of the endometrium. Compare with the healthy controls, patients with endometriosis of stages I/II and III/IV had significantly elevated positivity rate of HGF and c-Met expressions in either eutopic and ectopic endometrium, but without significant difference between the two patient groups (P<0.01). The rate of strong c-Met protein expression was significantly higher in III/IV endometriosis than in the controls, without statistical difference between other groups.
The expressions of HGF and c-met gene are correlated with the pathogenesis of endometriosis, which is preceded by eventful changes in the biological behavior of the eutopic endometrium.
研究肝细胞生长因子(HGF)及其受体(c-Met)在子宫内膜异位症发病机制中的作用。
采用原位杂交和免疫组化方法检测54例经腹腔镜和组织学检查确诊为子宫内膜异位症的育龄妇女(包括28例I/II期和26例III/IV期)在位和异位子宫内膜以及24例健康育龄妇女子宫内膜中HGF mRNA和蛋白的表达。
子宫内膜异位症患者在位和异位子宫内膜中HGF/c-Met表达的阳性率相似,但异位子宫内膜中阳性细胞数量和表达强度更高。子宫内膜增殖期和分泌期之间阳性表达率变化不大。与健康对照组相比,I/II期和III/IV期子宫内膜异位症患者在位和异位子宫内膜中HGF和c-Met表达的阳性率均显著升高,但两组患者之间无显著差异(P<0.01)。III/IV期子宫内膜异位症中c-Met蛋白强表达率显著高于对照组,其他组之间无统计学差异。
HGF和c-met基因的表达与子宫内膜异位症的发病机制相关,在位子宫内膜生物学行为的改变先于其发生。